A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay

scientific article published on 4 January 2017

A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.02166-16
P932PMC publication ID5328458
P698PubMed publication ID28053219

P50authorPaul R. LangfordQ42305832
Øystein AngenQ47505043
Marcelo GottschalkQ87139376
P2093author name stringØystein Angen
Andrew N Rycroft
Yanwen Li
László Fodor
Janine T Bossé
Katerina Nedbalcova
Rita Sárközi
P2860cites workComparative genomic characterization of Actinobacillus pleuropneumoniaeQ24632825
Multilocus sequence typing of a global collection of Pasteurella multocida isolates from cattle and other host species demonstrates niche associationQ28743363
Structural characterization of the antigenic capsular polysaccharide and lipopolysaccharide O-chain produced by Actinobacillus pleuropneumoniae serotype 15.Q30984108
Genome biology of Actinobacillus pleuropneumoniae JL03, an isolate of serotype 3 prevalent in ChinaQ33314919
Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infectionQ34552846
Evaluation of a multiplex PCR to identify and serotype Actinobacillus pleuropneumoniae serovars 1, 5, 7, 12 and 15.Q35174509
The genetic organization of the capsular polysaccharide biosynthesis region of Actinobacillus pleuropneumoniae serotype 15Q35594454
The genetic organization of the capsular polysaccharide biosynthesis region of Actinobacillus pleuropneumoniae serotype 14.Q35774598
Development of a Multiplex PCR Assay for Rapid Molecular Serotyping of Haemophilus parasuisQ36297610
Multiplex PCR that can distinguish between immunologically cross- reactive serovar 3, 6, and 8 Actinobacillus pleuropneumoniae strainsQ36452570
The complete genome sequence of Actinobacillus pleuropneumoniae L20 (serotype 5b).Q36452872
Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.Q36779547
The UDP-glucose dehydrogenase of Escherichia coli K-12 displays substrate inhibition by NAD that is relieved by nucleotide triphosphates.Q37095388
Characterization of the antigenic lipopolysaccharide O chain and the capsular polysaccharide produced by Actinobacillus pleuropneumoniae serotype 13Q37523907
The challenge of detecting herds sub-clinically infected with Actinobacillus pleuropneumoniaeQ38553231
Complete Genome Sequence of MIDG2331, a Genetically Tractable Serovar 8 Clinical Isolate of Actinobacillus pleuropneumoniaeQ38915859
Multiplex PCR assay for unequivocal differentiation of Actinobacillus pleuropneumoniae serovars 1 to 3, 5 to 8, 10, and 12.Q38915874
Detection of Mycoplasma hyopneumoniae in bronchoalveolar lavage fluids of pigs by PCR.Q39554471
Respiratory Disease in Kennelled Dogs: Serological Responses to Bordetella bronchiseptica Lipopolysaccharide Do Not Correlate with Bacterial Isolation or Clinical Respiratory SymptomsQ39752421
Identification of a proposed new serovar of Actinobacillus Pleuropneumoniae: Serovar 16.Q40898316
The capsule biosynthetic locus of Pasteurella multocida A:1.Q42684040
Structural characterization of the antigenic O-polysaccharide in the lipopolysaccharide produced by Actinobacillus pleuropneumoniae serotype 14.Q44869269
Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15.Q48330473
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectActinobacillus pleuropneumoniaeQ343332
P304page(s)902-907
P577publication date2017-01-04
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleA Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay
P478volume55

Reverse relations

cites work (P2860)
Q45954726Actinobacillus pleuropneumoniae biofilms: Role in pathogenicity and potential impact for vaccination development.
Q47767998An anti-Propionibacterium acnes antibody shows heterologous resistance to an Actinobacillus pleuropneumoniae infection independent of neutrophils in mice
Q47360727Application of an enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 15 in pig sera
Q89517827Basal-Level Effects of (p)ppGpp in the Absence of Branched-Chain Amino Acids in Actinobacillus pleuropneumoniae
Q55439484Comparative sequence analysis of the capsular polysaccharide loci of Actinobacillus pleuropneumoniae serovars 1-18, and development of two multiplex PCRs for comprehensive capsule typing.
Q89439988Detection of Actinobacillus Pleuropneumoniae ApxIV Toxin Antibody in Serum and Oral Fluid Specimens from Pigs Inoculated Under Experimental Conditions
Q92419437Etiology, epidemiology, pathology, and advances in diagnosis, vaccine development, and treatment of Gallibacterium anatis infection in poultry: a review
Q55173091Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
Q47139186Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.
Q46346618Identification of four type II toxin-antitoxin systems in Actinobacillus pleuropneumoniae
Q47216488In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.
Q58781087Incorporation of in Preformed Biofilms by Isolated From Drinking Water of Swine Farms
Q50113870Investigation of putative invasion determinants of Actinobacillus species using comparative genomics
Q88257682New trends in innovative vaccine development against Actinobacillus pleuropneumoniae
Q89440034Pig Lung Immune Cytokine Response to the Swine Influenza Virus and the Actinobacillus Pleuropneumoniae Infection
Q52609307Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis.
Q47728701Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges

Search more.